Markets:

Overview

News

Currencies

International

Treasuries

Keros Therapeutics, Inc. - common stock (NQ:KROS)

18.54 +0.75 (+4.22%)

Streaming Delayed Price Updated: 3:23 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Keros Therapeutics, Inc. - common stock

< Previous 1 2 3 Next >

Keros Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗

November 22, 2024

Via Benzinga

Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark ↗

September 05, 2024

Building your watch list, look for stocks with an 80-plus RS Rating. Keros Therapeutics stock just met that criteria with a new score of 86.

Via Investor's Business Daily

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 03, 2024

Via Benzinga

Keros Therapeutics Inc. (NASDAQ: KROS) Near the Top of Equities by Percentage Gain on 1/4

January 04, 2024

Via Investor Brand Network

Where Keros Therapeutics Stands With Analysts ↗

July 26, 2023

Via Benzinga

Recap: Keros Therapeutics Q1 Earnings ↗

May 04, 2023

Via Benzinga

Recap: Keros Therapeutics Q3 Earnings ↗

November 03, 2022

Keros Therapeutics (NASDAQ:KROS) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday ↗

September 03, 2024

Via Benzinga

KROS Stock Earnings: Keros Therapeutics Misses EPS for Q2 2024 ↗

August 07, 2024

KROS stock results show that Keros Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth ↗

June 25, 2024

Keros Therapeutics is advancing novel therapies for hematological and cardiopulmonary disorders via TGF-β signaling regulation. Oppenheimer rates KROS Outperform with a $102 price target.

Via Benzinga

KROS Stock Earnings: Keros Therapeutics Beats EPS for Q1 2024 ↗

May 08, 2024

KROS stock results show that Keros Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 04, 2024

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<

Via Benzinga

Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday ↗

January 04, 2024

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following...

Via Benzinga

Topics Stocks

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 11, 2023

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the...

Via Benzinga

Keros Therapeutics Posts Preliminary Data Early-Stage KER-012 Trial ↗

May 18, 2022

Via Benzinga

Keros Therapeutics Posts Encouraging Preclinical Data Of RKER-012 In Type Of High Blood Pressure ↗

May 18, 2022

Via Benzinga

Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday ↗

December 11, 2023

U.S. stocks traded mostly mixed, with the Dow Jones index gaining more than 100 points on Monday. Here are some other big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023 ↗

July 31, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023 ↗

July 26, 2023

Via Benzinga

Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 09, 2023

Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 144.5% to $0.7827.

Via Benzinga

Why Shares of Keros Therapeutics Jumped This Week ↗

April 21, 2023

The company appointed a new director and an analyst reiterated his position on the stock.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023 ↗

February 14, 2023

Via Benzinga

BioMedNewsBreaks – Keros Therapeutics Inc. (NASDAQ: KROS) Presents Clinical and Preclinical Data from Its Lead Hematological Programs at 64th ASH Event

December 13, 2022

Via Investor Brand Network

Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022 ↗

October 18, 2022

Upgrades

Via Benzinga

Why Shares of Keros Therapeutics Rose 10.2% This Week ↗

October 14, 2022

A sympathetic reaction to a competitor's drug helped push the clinical-stage pharmaceutical company's shares higher.

Via The Motley Fool

Alphatec Holdings, Immatics And Some Other Big Stocks Moving Higher On Monday ↗

October 10, 2022

U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Monday. Here are some big stocks recording gained in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022 ↗

July 26, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 18, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 23, 2022

On Thursday, 216 stocks hit new 52-week lows.

Via Benzinga

76 Biggest Movers From Yesterday ↗

May 19, 2022

Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.